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Abstract
Zoanthamine-type alkaloids display a wide spectrum of biological effects. This study aimed 
to examine the inhibitory effects of norzoanthamine and its ten homologues of zoanthamine 
class on human fibroblast collagenase by modeling a three-dimensional structure of the 
ligands at collagenase using energy minimization, docking, molecular dynamics simulation 
and MM-PB/GBSA binding free energy calculations. The results showed that zoanthamide, 
zooxathellamine and enol-iminium form of norzoanthamine, with lower binding free energies 
than other compounds, are potent inhibitors of collagenase. However, the enol-iminium form of 
norzoanthamine showed a more inhibitory activity against collagenase than its keto form. This 
suggests that it can be used for treatment of many diseases such as osteoporosis, autoimmune 
diseases, and cancer. Zinc-binding residues such as His 118, His 122 and His 128 for hydrogen 
bonds and Leu 81, Tyr 110, Val 115, Leu 126, Pro 138, Ser 139 for hydrophobic interactions 
should be considered for designing an inhibitor for collagenase. Our theoretical results and 
MM/GBSA binding free energy calculations are consistent with experimental studies.
Abbreviation
MD: Molecular dynamics; RMSD: Root mean square deviation; MM-PB/GBSA: 
Molecular mechanics Poisson-Boltzmann/General Born surface area, DFT: density functional 
theory, B3LYP: Becke, three-parameter, Lee-Yang-Parr, RESP: Restrained electrostatic surface 
potential
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Introduction
MMP-1(human fibroblast collagenase) is 
secreted by stromal fibroblasts, osteoblasts, and 
osteoclasts. It cleaves native collagen (abundant 
in bone matrix) at neutral pH (1). Overexpression 
of this enzyme is usually associated with the 
irreversible degradation of cartilage, tendon, and 
bone in people with arthritis (2). 
 Various types of mammalian 
collagenolytic enzymes are involved in the 
degradation of extracellular matrix including 
matrix metalloproteinases (MMPs), cathepsin 
K, and neutrophil elastase (3). The MMPs 
are members of a family of zinc-dependent 
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proteolytic enzymes. They mostly appear key 
players in endochondral ossification during 
embryonic development, modeling, remodeling 
and homeostasis of the skeletal system (4, 5).
A cumulative evidence supports that MMP-1 
cleavage activity is involved in many biological 
process such as keratinocyte migration and 
reepithelization, platelet aggregation, increased 
bioavailability of insulin-like growth factor 1 
(IGF-1), cell proliferation, protease activated 
receptor-1 (PAR1) activation and pro-
inflammatory and anti-inflammatory processes 
(for review, see reference 6 ). MMP-1 is also 
upregulated in tumor tissues and has been 
suggested to be associated with tumor invasion 
and metastasis (7). There is also a unifying link 
between MMP-1 and lung cancer risk (8). The 
MMP-1 significant contributions to these diverse 
biological and pathological conditions denote the 
probable involvement of this metalloproteinase 
in the pathogenesis of cancer and autoimmune 
diseases such as rheumatoid arthritis.
The active enzyme form of MMP-1 contains 
zinc- and calcium-binding catalytic domains 
with a COOH-terminal which may be involved 
in matrix binding. The structure is consisted 
of a twisted five-stranded beta sheet and three 
long helices. The collagenase active site cleft is 
bordered by a beta strand, a helix and a stretch of 
random coil adjacent to the COOH-terminus of 
that helix. The catalytic zinc is at the bottom of the 
cleft and is ligated by three conserved histidine 
residues, each at a distance of 2.1 Å. The second 
zinc ion is coordinated by two His and one Asp 
in an approximately tetrahedral manner. The 
calcium ion presented in the enzyme is ligated 
in an octahedral manner by two Asp and one 
Glu and two Gly and one Asn. Earlier studies 
demonstrated that zinc and calcium significantly 
stabilize the tertiary structure of collagenase (9).
Inhibition of MMP-1 activity may affect 
bone remodeling under certain pathological 
conditions. This can be related to the upregulation 
of interstitial metalloproteinases and bone 
loss. In order to selectively inhibit MMP-1 for 
therapeutic intervention, combined sophisticated 
theoretical and experimental approaches are 
required (10).
Studies on MMP inhibition, principally the 
structural determination of enzyme-inhibitor 
complexes, are crucial for understanding the 
structural features associated with inhibition. 
This information includes the scientific basis 
for a rational search for new and more potent 
inhibitors, through theoretical chemistry 
calculations (11, 12, 13).
Traditionally, the design of an MMP inhibitor 
(MMPi) has involved the use of zinc-binding 
groups due to the fact that MMP cleavage on 
substrates directly involves the catalytic Zn2+ 
ion(s) (14, 15, 16). Upon binding of the substrate, 
the zinc-bound water molecule attacks the 
substrate carbonyl carbon atom and the transfer 
of protons through a preserved Glu residue to 
the amide nitrogen of the scissile bond results 
in peptide cleavage (9). Therefore, zinc-binding 
groups (ZBG) in MMPi displace the zinc-bound 
water molecule and inactivate the enzyme (11). 
In addition, the ZBG acts as an anchor to lock the 
MMPi in the active site and directs the inhibitor 
into the target substrate-binding pockets.
As one of the members of zoanthamine class of 
marine alkaloids, there exist high concentrations 
of norzoanthamine in the epidermal tissues of 
Zoanthussp (17). Over the past 20 years, more 
than twelve nitrogenous marine metabolites 
known as zoanthamine alkaloids have been 
reported. They show a wide spectrum of 
biological effects including the inhibition of 
phorbolmyristate acetate-induced inflammation 
in mouse ear (18); inhibition of the growth of 
P-388 murine leukemia cell lines (19); inhibitory 
effects on thrombin-, collagen-, and arachidonic 
acid-induced human platelet aggregation (20); 
suppressive effects on interleukin-6 production 
(21); anti-osteoporosis activity in ovariectomized 
mice (22); acceleration in the formation of the 
type I collagen-hydroxyapatite composites 
(23); enhancement of collagen release from 
the immobilized matrix vesicle model and 
suppression of the proteolysis of bovine serum 
albumin, elastin and collagen (23).
Moreover, it has been suggested that collagen-
norzoanthamine supramolecular association 
may be the mode of anti-osteoporosis action 
of this marine alkaloid (23). The collagen 
protective activity of norzoanthamine suggests 
that these marine alkaloids may be a promising 
drug candidate for the prevention or treatment of 
osteoporosis-associated bone loss.
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Figure 1. Structure of norzoanthamine and its homologues (A) and enol-iminium tautomer of norzoanthamine  (B). The relative 
stereochemistry of molecules has been determined by an advances version of Mosher›s method.
In the present study, we examined the 
inhibitory effects of norzoanthamine and its 
homologues on human fibroblast collagenase by 
using theoretical chemistry studies.
Methods and Computational Details
The crystal structure of fibroblast 
collagenase was extracted from PDB bank 
(PDB code: 1CGL) (9). This structure refers 
to collagenase co-crystallized with an inhibitor 
(N-[(1s)-3-{[(benzyloxy) carbonyl] amino}-
1-carboxypropyl]-l-leucyl-N-(2-morpholin-4-
ylethyl)-l-phenylalaninamide) (OED). Since 
PDB structure has two identical chains and 
collagenase has only one chain, the chain A 
of protein was just retained for this study. 2D 
structures of the studied ligands (molecules 
1 to 10 and the molecule1 in its enol-imine 
tautomer known as ligand 1-enol), were drawn 
(Figure1) and minimized via Hyperchem 8 
software (24). They were then optimized at 
the density functional theory (DFT) level. The 
B3LYP hybrid functional was applied to these 
systems (25, 26). For electronic and structural 
investigations of ligands, the 6-31+G* basis 
set was considered. Finally, the vibrational 
frequencies were computed to elucidate the 
global minimum structure. All calculations were 
performed using the Gaussian 2003 program 
(27). The binding affinities between the ligands 
and the active sites of the enzyme were studied 
using docking studies (AutoDock 4.2 suites, 28). 
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MD simulation and MM-PB/GBSA binding free 
energy calculations were performed via Amber 
package version 12 (29). All calculations were 
repeated with a crystallographic ligand (OED) as 
control. Afterwards, eleven ligands were studied.
Molecular docking
All ligands plus the co-crystallized inhibitor 
(OED) were docked into the chain A of original 
PDB file. The estimated binding affinities 
between the ligands and the active sites of the 
enzyme were then explored by docking studies 
(AutoDock 4.2 suites) (28). Input files required 
for AutoDock 4.2 were made in Autodock Tools 
(ADT) (Autodock Tools, 3.0). The Gasteiger 
charges were assigned to the ligands. All files 
were converted to the PDBQT format needed for 
Autodock calculations. The protein and ligand 
were considered rigid and flexible, respectively 
during docking procedure. 
At first, docking calculations were carried 
out with performing a blind docking. The grid 
box was centered on the original ligand position 
of the crystal structure (OED). Then the lowest 
docking energy of each ligand was selected. 
Further docking calculations were done to obtain 
the top-ranked pose.
All hydrogen atoms were added to the 
collagenase protein and after assigning Kollman 
united atom charges and atomic solvation 
parameters, then the non-polar hydrogens 
merged. The size of the grid box for final docking 
to specify the search space was set at 60×60×60, 
and centered on the predicted cavities with 
a default grid point spacing of 0.375 Å. Pre-
calculated grid maps storing interaction energy 
of the ligand atom type with the receptor target, 
were obtained using AutoGrid4. 
The zinc parameters used in this study were 
radius(r = 1.1Å) and well depth (ε = 0.25 Kcal/
mol) (31). A charge of +2.0 e was assigned to the 
zinc and calcium ions (31) in PDBQT file.
Figure 2. RMSD of protein backbone and RMSD of ligands during 10 ns MD simulation.
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The Lamarckian Genetic Algorithm (LGA) 
(28) was used for a conformational search 
approach with 200 runs of Genetic Algorithm 
runs. A maximum number of 2,500,000 energy 
evaluations per run were carried out, while 
crossover and mutation rates were run with 
the default parameter settings. The step size 
parameters were changed, i.e. "Translation" to 
0.2 Å, "Quaternion" to 5.0°, and "Torsion" to 
5.0°.
AutoDock4.2 applied to evaluate the binding 
free energy was used to discover the best 
binding mode. The energy scoring values of 
AutoDock4.2 are consisted of intermolecular 
energy (van der Waals, hydrogen bonding, 
desolvation and electrostatic energies), total 
internal energy and torsional free energy. In fact 
the lower the binding free energies, the more 
effective the ligand-binding protein. The root-
mean-square deviations of ligands (RMSD) were 
calculated in order to put them into families of 
similar conformations or "clusters". Therefore, 
the expected docked complexes are preferred 
based on the lowest binding free energy from the 
largest"clusters" for each ligand.
The docked conformations of each ligand 
were ranked into clusters based on the binding 
energy. The results were clustered with the 
tolerance of 2.0 Å RMSD. Based on the lowest 
binding free energy of the most populated cluster, 
the best position of each ligand was chosen for 
subsequent studies.
Molecular dynamics (MD) simulations
The best docked complexes were selected 
for MD simulations. Twelve MD simulations 
(11 ligand and OED) were performed using 
the Amber12 package (29). The protein was 
modeled using the AMBER FF99SB force field. 
The inhibitor charges were obtained using the 
RESP fitting procedures (32). Topology prep 
files for ligands were built with the general amber 
force field (gaff) using Antechamber module in 
AmberTools12 (33). The complexes were then 
Figure 3. Distance (Å) between center of mass of collagenase and ligands during 10 ns MD simulation.
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solvated in a truncated octahedral box of TIP3P 
(34) water molecules with a buffer size of 12 Å, 
and neutralized using 10 Na+ ions. The default 
protonation of Amber12 was used for titratable 
residues in protein.The energy minimization and 
MD simulations were performed for each system 
using the SANDER module of the Amber12 
package (29).First, 10000 cycles of minimization 
(MAXCYC) with the first 700 steps of steepest 
descent (NCYC) and 9300 steps of conjugate 
gradients on all atoms of the system were 
performed to relieve the bad steric interactions 
and to get closer to an energy minimum. After 
energy minimization, the position restraints 
at constant volume (NVT) for 100 ps, with a 
restraint force of 10 Kcal/mol at temperature of 
100 K, and then at constant pressure (NPT) for 
100 ps, with a restraint force of 1 Kcal/mol at 
temperature of 300 K, were performed. 
Next, an equilibration step at constant 
pressure (NPT) at 300 K was performed. The 
duration time in this step was 100 ps and the 
time step was 2 fs, while the restraint force 
was removed in this step. This approach allows 
the water to equilibrate around the protein and 
come to an equilibrium density. In the position 
restraints and equilibration steps, Langevin 
dynamics were used to control temperature.
Finally, a production step for 10 ns with a 2 
fs time step at constant pressure (NPT ensemble) 
and with an isotropic position scaling (ntp = 1) at 
300 K was carried out. In this step, the Berendsen 
thermostat was used to control temperature (ntt 
= 1). All bonds with hydrogen atoms in all steps 
were constrained via the SHAKE algorithm (35) 
(ntc = 2, ntf = 2). The periodic boundary was 
used in all steps (ntb = 1).
The long-range electrostatic interactions 
were treated using the particle mesh Ewald 
method (36), and a nonbonded cutoff was set to 
10 Å. The zinc and calcium ions were connected 
to related residues via tleap module of Amber12. 
The images of ligands in the active site of protein 
were generated with LigPlus (37).
MM-PB/GBSA calculations
Molecular mechanics Poisson Boltzmann/
surface area (MM-PBSA) is regarded as an 
attractive approach for drug design since it 
works not only for small and medium size 
organic compounds but also for the biological 
molecules such as proteins and DNA. The MM/
Table 1. Electronic energy and electrostatic and van der Waals energies and the lowest binding energy from docking results.
Molecule Eelectronc+ZPVE1
vdw+hbond +desolvation 
Energy Electrostatic Energy ΔGbinding
2 
Ligand 1-keto -978081 -7.13 +0.04 -7.09
Ligand1-enol -978031 -5.39 -8.20 -12.09
Ligand 2 -1002726 -7.28 -0.04 -7.32
Ligand 3 -1095966 -8.49 -0.21 -8.40
Ligand 4 -1096901 -8.72 +0.08 -8.05
Ligand 5 -1049180 -7.81 -0.11 -7.92
Ligand 6 -1049920 -8.84 0.05 -8.30
Ligand 7 -1024538 -7.57 0 -7.56
Ligand 8 -1019399 -6.04 -1.27 -6.72
Ligand 9 -978473 -7.35 -0.09 -7.14
Ligand 10 -1004747 -7.62 -0.09 -7.42
OED -1309458 -9.31 -6.79 -9.54
1 Electronic energy (kcal/mol).
2 The lowest binding free energy from docking calculations (kcal/mol).
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RMSD of protein backbone RMSD zinc and calcium ions RMSD of ligands Distance 
Ligand 1-keto 2.08±0.19 1.02±0.11 1.62±0.05 38.16±18.35
Ligand 1-enol 1.87±0.2 1.05±0.1 1.06±0.07 13±0.34
Ligand 2 2.73±0.24 1.05±0.22 1.35±0.06 26.13±6.35
Ligand 3 1.97±0.28 0.53±0.12 1.85±0.1 20.81±2.09
Ligand 4 2.3±0.3 1.32±0.3 2.1±0.1 15.41±0.65
Ligand 5 1.7±0.37 0.8±0.1 1.45±0.1 26.26±7.4
Ligand 6 2.3±0.4 1.01±0.14 1.5±0.05 22.92±2.74
Ligand 7 3.5±0.44 0.94±0.1 1.35±0.1 14.2±1.12
Ligand 8 2.2±0.2 0.93±0.25 1.08±0.1 17.7±1.07
Ligand 9 2.9±0.56 1.3±0.25 1.06±0.07 18.12±1.4
Ligand 10 2.15±0.33 0.81±0.11 1.18±0.06 11.5±0.27
OED 4.3±0.2 1.04±0.14 2.88±0.26 12.81±0.34
Table 2. The average and standard deviations of RMSD (Å) of protein backbone and ligand atoms and also RMSD of zinc and calcium 
ions at the last 4 ns of 10 ns MD simulation. In addition, distance (Å) between center of mass ligands and protein during 10 ns MD 
simulation was mentioned. 
Figure 4. LigPlus pictures of ligand OED (A), ligand 1-enol (B), ligand 4 (C) and ligand 10 (D) in the active site of collagenase after 10 
ns MD simulation. Hydrogen bonds were shown with green dotted line. Hydrophobic interactions were shown in thicker lines.
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PBSA is a molecular dynamics based approach 
that is fast and practical for binding free energy 
calculations, in spite of free energy perturbation 
(FEP) or thermodynamics integration (TI) that 
are time-consuming. Also, unlike the linear 
interaction energy (LIE) method, MM-PBSA 
applies no empirical parameters in its free 
energy calculations. It does not need a training 
set to derive the empirical parameters as does 
LIE, which makes it a promising method 
for ranking very different compounds from 
database searching for binding to a given site 
(38). Therefore, by combining this method with 
molecular docking and molecular dynamics 
simulations, one can hope to reliably model a 
protein and DNA complex (38).
The binding energies in this study were 
calculated by the MM-PBSA method as 
implemented in Amber 12 (39-43). Four hundred 
snapshots were extracted from MD simulation 
trajectories for binding free energy calculations. 
The water molecules and counter-ions were 
stripped.
In summary, the binding free energy is:
 Eq(1)
Each free energy term in Eq (1) is computed 
using Eq(2):
      
 Eq(2)
The entropy term is written as T∆S. ∆Egas 
stands for the gas phase or vacuum molecular 
mechanical energy and can be divided into the 
van der Waals, electrostatic, and the internal 
energy contributions in gas phase. ∆Gsolvation is 
the solvation free energy and estimated using 
continuum solvent methods. It can be partitioned 
into two parts: the polar contribution (∆G(PB/
GB)) and the nonpolar contribution (∆Gnonpolar) as 
shown in Eq(3).
  
    Eq(3)
The electrostatic solvation free energy was 
determined using the finite difference PB or 
GB models. The nonpolar contribution to the 
solvation free energy was calculated from the 
solvent accessible surface-area.
      
 Eq(4)
Where ∆SASA (solvent accessible surface-
area) was determined with linear combinations 
Table 3. The average and standard deviations of temperature (K) of kinetic (EKCMT ) and potential (EPTOT) and total (ETOT) energies 
(kcal/mol) and density (gr/cm3) during 10 ns MD simulation for all complexes.
Temperature EKCMT EPTOT ETOT Density
Ligand 1-keto 299.96± 1.48 6481± 56 -75284± 4 -60449± 39 1.024± 0.001
Ligand 1-enol 299.96±1.49 6480± 57 -75210±83 -60370± 37 1.024± 0.001
Ligand 2 299.96± 1.49 6469± 57 -75147± 84 -60329± 39 1.024± 0.001
Ligand 3 299.96±1.49 6478± 57 -75272± 5 -60437± 41 1.024± 0.001
Ligand 4 299.96± 1.49 6481± 57 -75858±85 -61020± 42 1.025± 0.001
Ligand 5 299.96±1.49 6471± 57 -75179±83 -60360± 38 1.024± 0.001
Ligand 6 299.96±1.49 6477± 57 -75245± 84 -60412±39 1.024± 0.001
Ligand 7 299.96 ±1.49 6475 ±57 -75276±89 -60450± 6 1.024 ±0.001
Ligand 8 299.97 ±1.48 6467 ±57 -75163±83 -60351± 40 1.024 ±0.001
Ligand 9 299.96± 1.49 6480± 57 -75271±83 -60435± 38 1.024± 0.001
Ligand 10 299.96±1.48 6470± 57 -75110±86 -60289± 43 1.023± 0.001
OED 299.96±1.48 6501± 57 -75738± 89 -60847± 49 1.024± 0.001
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of pairwise overlaps (LCPO) method (44). The 
corresponding solvation parameters γ and b 
are 0.00542 Kcal/molÅ2 and 0.92 Kcal/mol, 
respectively for the PB method, and 0.0072 
Kcal/molÅ2 and 0 Kcal/mol respectively, for the 
GB method. The probe radius of the solvent was 
set to 1.4 Å. PARSE radii were used in solvation 
model (45). The obtained conformational 
entropy change upon ligand binding (T∆S) 
from the sum of the translational, rotational and 
vibrational components, was computed using 
quasi-harmonic entropy approximation. In this 
study, the single trajectory approach was applied 
to estimate the energies. This means that the 
protein and ligand geometries were taken from 
protein-ligand complex, thus there is no internal 
energy contribution to the net molecular-
mechanical binding energy (∆Egas). Estimation 
of energies in this manner has been proven 
successful in many studies (46). The separate 
trajectory approaches in which three trajectories 
of complex, free receptor and free ligand used 
for energy calculations were deficient in practice 
due to the limitations of sampling and large 
fluctuations. 
Results
The results of the computations performed 
in the present work were divided into three 
sections according to the applied computational 
techniques for ligands studies.
All vibrational frequencies of the ligands 
were positive (data not shown), suggesting the 
optimized structures from all ligands had been 
in the global minimum of the potential energy 
surfaces.
All of the docking modes were near catalytic 
zinc ion (Zn 169) in the active site of the enzyme. 
The second column of Table 1. shows the 
electronic energy for all optimized geometries 
of ligands at B3LYP/6-31+G* level of theory. 
The third column shows the van der Waals 
and hydrogen bonds plus desolvation energy 
components of estimated docking energies. 
Electrostatic interactions and the lowest binding 
free energy of each ligand in the active site of 
collagenase have been shown in the 4th and 5th 
columns, respectively.
The results of top-ranked docking pose 
conformers of the ligand 1 in its keto and enol-
iminium are interesting. As seen in Table 1. the 
enol-iminium form of norzoanthamine shows 
a much more inhibitory effect than its keto 
form and its estimated binding energy is lower 
than all ligands. The enol-iminium tautomer of 
norzoanthamine was investigated as a model of 
norzomanthamin hydrochloride.
Molecular dynamics simulations
Based on the initial structures of the systems 
from the molecular docking, MD simulations 
were performed to observe the dynamic 
behavior of the investigated ligands in the active 
site of collagenase and to check the stability of 
the docked complexes. To evaluate the quality 
of MD simulations, the structural properties of 
the receptor–ligand complexes were monitored 
during the MD trajectories of each system.
Figure 2. shows the RMSDs of ligand atoms 
and the protein backbone atoms against their 
initial positions. The average RMSD values of 
the last 4 ns of 10 ns MD simulation for backbone 
atoms of the proteins in addition to all atoms of 
the ligands plus zinc and calcium atoms, relative 
to their initial positions were displayed in Table 
2. As seen, the protein and ligand structures are 
relatively stable in all of the twelve simulation 
systems (11 norzoanthamine homologue and 
OED). These results show that the simulations 
were stable with a maximum average RMSD of 
about 4.3 Å for protein backbone in complex with 
OED. The average RMSD of protein backbone 
in complex with other ligands was about 2 Å 
(Table 2). In general, the systems followed the 
same trend in all cases during the simulations, 
and the RMSDs tended to converge in the early 
phase of the simulations.
The position of zinc and calcium ions were 
stable during the MD simulations as the average 
maximum RMSDs of these atoms is about 1.3 Å 
with a trivial standard deviation. 
For temperature and energy conservations, 
a slight fluctuation was observed in all of the 
systems during the first 1 ns of simulation then 
flattened out for standard deviations of less than 
1.5 K for the temperature and about 90 Kcal/mol 
for potential energy (Table 3). Minor changes in 
standard deviation of temperature, potential and 
kinetic, total energies and density during 10 ns 
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MD simulations (Table 3) show that the length 
of MD simulation was adequate for production 
step and that simulations were stable under 
simulation conditions.
Figure 3. and Table 2. show the distance 
between the centers of mass of protein and ligands 
during 10 ns MD simulation. These results and 
the visual inspection of final structures indicate 
that ligand 4, 10, 1-enol and OED reside in the 
active site of the enzyme, but other ligands go 
away from active site (data not shown). This 
finding was confirmed with snapshot with the 
lowest potential energy across the simulation.
Figure 4. shows LigPlus (37) presentation 
of ligand OED, 1-enol, 4 and 10 in the active 
site of collagenase after 10 ns MD simulation 
(final structures). In complex of ligand OED 
with the protein Gly 79, Asn 80, Leu 81, His 
118, His 128, Pro138, Tyr 140 residues make 
hydrogen bonds with OED. The analysis of 
complex trajectories shows that Asn 80 and Glu 
119 have hydrogen bonds with OED ligand at 
the major part of simulation time. In addition, 
Tyr 110 and Val 115, Ser 139 have hydrophobic 
interactions with ligand OED (Figure 4A). The 
enol-iminium form of norzoanthamine (1-enol) 
has interactions with catalytic zinc ions; while 
this interaction is absent in its keto form   The 
carboxyl group of 1-enol ligand (O3 and O4 in 
Figure 4B) with the negative charge makes a salt 
bridge with catalytic zinc ion with the positive 
charge. Some hydrogen bonds were observed 
between the NE2 atoms of His 118, 122, 128 
and hydroxyl and carboxyl groups of ligand 
1-enol (O2, O3 and O4 at Figure 4B). Also, the 
analysis of complex trajectories of 1-enol shows 
that Glu 119 has hydrogen bonds with ligand 
1-enol at the major part of simulation time. In 
addition, hydrophobic interactions of Ala 82, His 
83, and Tyr140 were detected with aza-bicyclo 
octane tail of ligand 1-enol, orientating deeply 
into the Zn169 pocket of collagenase. In ligand 
4, ketonic oxygen (O7 in Figure 4C) of lactone 
(tetrahydropyran) tail makes hydrogen bond 
with NE2 atoms of His 118 and His 128 and 
lactone tail has hydrophobic interactions with 
Pro 138 and Leu 81 (Figure 4C). In ligand 10, 
ketonic oxygen of lactone makes hydrogen bond 
with ND1 atom of His 128. Also, oxygen of aza-
bicyclooctane makes hydrogen bond with amide 
nitrogen of Ala 84. His 83, Val 115 and Leu 
126 have hydrophobic interactions with ligand 
10, which stabilizes the complex (Figure 4D). 
Finally, ligand 1-enol, 4 and 10 have similar 
hydrogen bonds with crystallographic ligand 
(OED).
Binding free energy calculations
In order to explore the inhibition strength 
of all investigated ligands with collagenase 
active site, the MM-GB/PBSA method (47) was 
used. This method calculates the binding free 
Figure 5. Distance of center of mass ligands and protein (Å) against Generalized Born binding free energy (∆GGB) (Kcal/mol) without 
entropy.
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energies of ligands 1 through 10, Also ligand 
1 in its enol-iminium tautomer and OED with 
collagenase (Table 4). Without considering 
OED ligand, the lowest binding free energy 
belongs to ligand 1-enol. However, for most 
complexes investigated, the contributions of 
the entropy changes (TΔS) to the free energies 
almost weakened the binding of inhibitors to 
collagenase.
It has been shown in earlier studies that 
neglecting the entropy effects of a set of 
analogues ligand binding to the same receptor 
results in good agreement between the calculated 
and experimental relative binding free energies 
(46). Similarly, in the present study, entropy 
contribution (T∆S) changed from -46 to -80 Kcal/
mol at 298.15 K (except ligand 1-enol) (Table 
4). Consequently, the entropy contributions were 
indeed neglected as we are only interested in the 
relative order of binding affinities and there was 
no experimental binding free energy of these 
ligands to the collagenase.
Without considering entropy effects, the 
ΔGbinding, calculated for all ligands ranged from 
−595 to 71 Kcal/mol, based on the Generalized 
Born method. Ligand 1-enol had the most 
negative ΔGbinding value (−201.37 Kcal/mol for 
MM-GBSA) and ligand 5 had the largest binding 
free energy value (71.42 Kcal/mol) (Table 4). 
Interestingly, there was a positive regression 
between docking energy and Generalized Born 
binding energy with and without entropy as in 
both cases; the regression coefficient between 
them was about 41 percent. On the other hand, 
there was no regression between docking and 
Poisson-Boltszmann/surface area binding 
energy (R2 = 0.07).
According to the energy components of the 
binding free energies listed in Table 4. both 
electrostatic (∆Eelec+∆GGB) and van der Waals 
plus hydrophobic (∆Evdw+∆GSA) energies are 
important for ligand 4 and OED. In ligand 
4, electrostatic interactions between ketonic 
oxygen of lactone ring and zinc ion keep this 
ligand in the active site of the enzyme.
In the case of the ligand 1-enol, contribution 
of electrostatic interactions (∆Eelec+∆GGB) in 
binding free energy is more important than 
van der Waals plus hydrophobic interactions 
(∆Evdw+∆GSA). In other words, in the ligand 
1-enol, the salt bridge between carboxyl oxygen 
and zinc ion is favorable, but van der Waals 
and hydrophobic interactions of Ala 82, His 
83, Tyr 140 with aza-bicyclo octane group are 
molecule ∆G
GB
a ∆G
GB
b ∆G
PB
a ∆G
PB
b ∆Eelec+∆GGB ∆Eelec+∆GPB ∆Evdw+∆GSA T∆S
Ligand 1-keto -19.8 26.26 -4.06 42 5.01 3.17 34.15 -46.06
Ligand 1-enol -201.37 -141.44 -32.40 27.54 -155.2 -34.36 32.02 -59.93
Ligand 2 65.04 118.88 88.46 142.3 5.32 4.24 29.69 -53.83
Ligand 3 -34.80 20.41 -4.28 50.93 10.01 9.17 22.30 -55.21
Ligand 4 -62.99 17.82 29.82 110.63 -45.07 15.48 -17.92 -80.81
Ligand 5 71.42 129.99 88.63 147.20 4.40 4.03 36.28 -58.57
Ligand 6 59.67 128.02 90.82 159.18 9.29 9.51 24.06 -68.36
Ligand 7 -67.58 -1.25 9.78 76.11 18.77 47.52 10.25 -66.33
Ligand 8 -36.33 23.90 6.01 66.25 7.79 13.19 18.35 -60.23
Ligand 9 -32.16 24.2 5.34 61.69 12.49 11.08 16.96 -56.35
Ligand 10 -44.38 21.6 15.71 81.7 24.68 24.39 -4.18 -65.99
OED -595.96 -481.17 -447.82 -333.03 -63.77 7.66 -12.61 -114.8
a: Without entropy approximation ( .                                                                                                                                            
b: Using quasi-harmonic entropy approximation ( ).
Table 4. The Generalized Born (∆GGB) and Poisson-Boltszmann (∆GPB) binding free energy and electrostatic and hydrophobic and 
entropy contribution (T∆S) in free energy binding in Kcal/mole at 298.15 K.
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not very well with unfavorable contribution. 
In binding ligand 10, van der Waals and 
hydrophobic interactions are the major favorable 
contributors of binding. This finding suggests 
that the interaction mechanisms of these ligands 
may differ from the others. These results are 
consistence with docking results (Table 1).
There is a positive regression between 
distance of the  mass centers of ligands and 
protein (Table 2) and Generalized Born binding 
free energies without entropy (Table 4).Without 
consideration of the ligand 1, 1-enol and OED 
(as outliers), the regression coefficient between 
them is about 80 percent. Figure 5 shows that 
an analogy can be seen between MD simulations 
and binding free energy calculations. It seems 
that in the current study the Generalized Born 
method has been more applicable than Poisson-
Boltszmann/surface area one.
Discussion
Based on the obtained results of the molecular 
docking, molecular dynamics simulation, 
and MM/GBSA binding free energy ligand 
1-enol, ligand 4 (zoanthamide), and ligand 
10 (zooxathellamine) stay in the active site of 
enzyme during 10 ns MD simulation and show 
higher inhibitory effects towards collagenase 
relative to other norzoanthamine derivatives. 
These compounds are able to interact with 
the active pocket of collagenase by several 
hydrogen bonds, hydrophobic contacts, and 
make a salt bridge with catalytic zinc with 
negative Generalized Born binding free energy. 
In addition, the ligand 1-enol is better inhibitor 
than the ligands 4 and 10. The ligand1-enol has 
significant inhibitory effects on MMP-1 through 
interactions with the catalytic zinc. The results 
show that enol-iminium form of norzoanthamine 
(as a model to norzoanthamine hydrochloride) 
interacts with the catalytic zinc however the keto 
form of norzoanthamine does not. On the other 
hand, Yamaguchi (22) have reported in-vivo 
anti-osteoporosis activity of norzoanthamine 
hydrochloride through experimental studies. 
They showed that the oral administration of 
norzoanthamine hydrochloride completely 
suppressed the loss of trabecular bone, and 
thickened the cortical bone in ovariectomized 
mice (22). Theoretical results of the present 
study showed that the inhibitory effect of the 
ligand 1-enol was more than ligand 1. Therefore, 
it can be claimed that a possible mechanism of 
norzoanthamine hydrochloride action may be 
through inhibition of collagenase I.
The development of synthetic and natural 
MMP-1 inhibitors such as the ligand 1-enol, 
promises for not only novel therapeutic 
measures for the prevention and treatment of 
osteoporosis, but it will also provide potential 
therapeutics for the modulation of extracellular 
matrix remodeling, and the disturbances of the 
microenvironment involved in the pathogenesis 
and disease progression of some cancers and 
autoimmune diseases.
The mode of the anti-osteoporosis effects 
of norzoanthamine (ligand 1) was heavily 
investigated by Kinugawa et al. and some other 
workers (23). They found that norzoanthamine 
protects collagen from proteolytic cleavage 
and stabilizes its secondary structure. Recently, 
Genji (17) showed that norzoanthamine probably 
protects collagen by increasing its resistance to 
UV light. Norzoanthamine inhibits collagenase 
activity against type I collagen (17, 23). It has 
been suggested that norzoanthamine has no 
interaction with the active sites of collagenase, 
but it makes a non-covalent interaction with 
collagen, protecting it from proteolytic cleavage 
(23). Our theoretical results are consistence 
with above experimental results and show that 
norzoanthamine (ligand 1) could not stay in the 
active site of collagenase and that its binding free 
energy is positive.It is noteworthy to mention 
that in future theoretical studies, it would 
be interesting to investigate the interaction 
of norzoanthamine with collagen. Different 
modifications of norzoanthamine may improve 
its interaction with collagen.Therefore, based 
on the obtained results from Table 4 and Figure 
4. it can be concluded that a good inhibitor of 
collagenase makes a salt bridge with zinc ion 
169 and hydrogen bonds with His 118, His 122, 
His 128 and hydrophobic interactions with Leu 
81, Tyr 110, Val 115, Leu 126, Pro 138, Ser 139.
Conclusions
Some of nitrogen marine metabolites known 
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as zoanthamine alkaloids act as robust inhibitors 
of MMP-1. Theoretical and experimental studies 
are consistent in the case of OED ligand and 
norzoanthamine and its enol-iminium form of 
norzoanthamine. An effective administration of 
MMP-1 inhibitors is beginning a new treatment 
approach in the management of many diseases 
such as osteoporosis, autoimmune diseases and 
cancer.
Hence, conducting clinical trials on synthetic 
and natural zoanthamine marine alkaloids 
promises  exciting in many groundbreaking 
experiments such as anti-osteoporosis effects 
of ligand 4 (zoanthamide) and ligand 10 
(zooxathellamine) and their derivates (enolic-
iminuim forms). The detailed description of 
protein-inhibitor interactions will aid in the 
design of compounds that selectively inhibit 
individual members of the MMP family. Such 
inhibitors will be useful in examining the 
function of MMPs in pathological processes.
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